T-5224
mRNA synthesis
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
Tyramide Signal Amplification (TSA)
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Phos Binding Reagent Acrylamide
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
Cell Counting Kit-8 (CCK-8)
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
SYBR Safe DNA Gel Stain
Safe and sensitive stain for visualization of DNA or RNA in agarose or acrylamide gels.
Inhibitor Cocktails
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
T-5224 is a non-peptidic, small molecule and novel inhibitor of c-Fos/AP-1 [1].
T-5224 has shown the specific inhibition in a c-Fos/AP-1promoter-luciferase assay, without affecting the levels of c-Fos family protein members themselves. In addition, T-5224 has been reported to selectively inhibit the DNA binding activity of c-Fos/c-Jun, without affecting those of other transcription factors(C/EBPα and ATF-2, MyoD, Sp-1 and NF-κB/p65). Some research has been suggested that T-5224 potently suppressed the development of collagen-induced arthritis (CIA). Besides, T-5224 has been evidenced to inhibit the expression of nuclear factor of activated T-cells (NFAT) and osteoclastogenesis of the macrophage-osteoclast precursor RAW264.7cells induced by receptor activator of NF-κB ligand (RANKL). Apart from these, T-5224 has been noted to inhibit in-vitro production of the mediators (MMP-1, MMP-3, IL-6 and TNF-α) in IL-1β-stimulated human synovial SW982 cells with the mean IC50 of about 10μM. In the in vivo pharmacokinetic analysis, the ED50 of T-5224 is about 1-10mg/kg, and the Cmax is 0.03-0.5μM [1].
References:
[1] Aikawa Y1, Morimoto K, Yamamoto T, Chaki H, Hashiramoto A, Narita H, Hirono S, Shiozawa S. Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1. Nat Biotechnol. 2008 Jul;26(7):817-23.
- 1. Drummond RA, Swamydas M, et al. "CARD9(+) microglia promote antifungal immunity via IL-1β- and CXCL1-mediated neutrophil recruitment." Nat Immunol. 2019 May;20(5):559-570. PMID:30996332
- 2. Lv SY, Cui B, et al. "Spexin/NPQ Induces Fos and Produces Antinociceptive Effect against Inflammatory Pain in the Mouse Model." Am J Pathol. 2019 Jan 19. pii:S0002-9440(18)30290-6. PMID:30664863
- 3. Choi Y, Rosewell KL, et al. "FOS, a Critical Downstream Mediator of PGR and EGF-signaling Necessary for Ovulatory Prostaglandins in the Human Ovary." J Clin Endocrinol Metab. 2018 Aug 16. PMID:30124866
- 4. Levi NJ, Wilson CW, et al. "Obesity-related cellular stressors regulate gonadotropin releasing hormone gene expression via c-Fos/AP-1." Mol Cell Endocrinol. 2018 Jul 29. pii: S0303-7207(18)30235-1. PMID:30063946
- 5. Chih-Wei Chen. "WNT5A induziert über eine JNK-abh?ngige Aktivierung von latentem TGF-β Fibrose." Friedrich-Alexander-Universit?t Erlangen-ürnberg.2018/01/15.
- 6. Isha Dey, Neil A. Bradbury. "Activation of TPA-response element present in human Lemur Tyrosine Kinase 2 (lmtk2) gene increases its expression." Biochemistry and Biophysics Reports. 2017 September 21.
- 7. Shao YY, Hsieh MS, et al. "Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells." Oncotarget. 2017 Sep 30;8(49):86681-86692. PMID:29156827
- 8. Jang B, Ishigami A, et al. "The Peptidylarginine Deiminase Inhibitor Cl-Amidine Suppresses Inducible Nitric Oxide Synthase Expression in Dendritic Cells." Int J Mol Sci. 2017 Oct 27;18(11). pii: E2258. PMID:29077055
- 9. Johannessen L, Sundberg TB, et al. "Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells. "Nat Chem Biol. 2017 Oct;13(10):1102-1108. PMID:28805801
- 10. Chen H, Qu J, et al. "Mechanosensing by the α6-integrin confers an invasive fibroblast phenotype and mediates lung fibrosis." Nat Commun. 2016 Aug 18;7:12564. PMID:27535718
| Physical Appearance | A solid |
| Storage | Store at -20°C |
| M.Wt | 517.53 |
| Cas No. | 530141-72-1 |
| Formula | C29H27NO8 |
| Solubility | ≥25.88mg/mL in DMSO |
| Chemical Name | 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-oxo-2,3-dihydrobenzo[d]isoxazol-6-yl)methoxy)phenyl)propanoic acid |
| SDF | Download SDF |
| Canonical SMILES | O=C1NOC2=CC(COC(C=CC(C(C3=C(O)C=C(OC4CCCC4)C=C3)=O)=C5)=C5CCC(O)=O)=CC=C12 |
| Shipping Condition | Evaluation sample solution : ship with blue ice.All other available size: ship with RT , or blue ice upon request |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. |
| Kinase experiment [1]: | |
|
Inhibitory activities |
The DNA binding activity of transcription factors was measured using the TransAM kits (Active Motif). Nuclear extracts containing factors such as c-Fos/AP-1, c-Jun/AP-1, ATF-2, C/EBPa, MyoD, Sp-1 or NF-kB/p65 and various concentrations of T-5224 were added in the multi-well plates precoated with respective consensus double-stranded (ds)DNA oligomers. After incubation for 1 h, the transcription factor bound to its respective consensus dsDNA sequences was detected by using antibodies reactive against the respective transcription factors according to the manufacturer’s protocol. |
| Cell experiment [2]: | |
|
Cell lines |
Human synovial SW982 cells; human chondrocyte SW1353 cells |
|
Preparation method |
Dissolved in DMSO. General tips for obtaining a higher concentration: Please warm the tube at 37℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months. |
|
Reaction Conditions |
0.1, 1, 10, 100, 1000 μM. |
|
Applications |
In human synovial SW982 cells stimulated by IL-1β, T-5224 inhibits the production of MMP-1, MMP-3, IL-6 and TNFα. In human chondrocyte SW1353 cells stimulated by IL-1β, T-5224 inhibits the production of MMP-3 and MMP-13 with IC50 value of 10 μM. |
| Animal experiment [3]: | |
|
Animal models |
Male DBA/1J mice with type II collagen–induced arthritis (CIA). |
|
Dosage form |
0.3, 1, 3, 30 mg/kg, once daily from day 21, before the onset of arthritis; administered orally. |
|
Applications |
T-5224 significantly inhibits the development of arthritis by 64% and 91% on day 50 at 3 and 30 mg/kg, respectively. T-5224 inhibits joint destruction and completely protects the joint from destruction at 30 mg/kg. At 30 mg/kg dose, T-5224 significantly inhibits MMP-2, MMP-3, MMP-9, MMP-13, IL-1β, IL-6 and TNFα. |
|
Other notes |
Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
|
References: [1]. Aikawa Y, Morimoto K, Yamamoto T, et al. Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1. Nat Biotechnol, 2008, 26(7): 817-823. | |
Quality Control & MSDS
- View current batch:
Chemical structure
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
